Certara Appoints Jon Resnick as Chief Executive Officer

Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth

GlobeNewsWire • Dec 11, 2025

Earnings Estimates Moving Higher for Certara (CERT): Time to Buy?

Certara, Inc. (CERT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research • Dec 8, 2025

Wall Street Analysts Think Certara (CERT) Could Surge 43.28%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 43.3% in Certara (CERT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Dec 8, 2025

Cerrado Gold Inc. (CERT:CA) Q3 2025 Earnings Call Transcript

Cerrado Gold Inc. (CERT:CA) Q3 2025 Earnings Call Transcript

Seeking Alpha • Dec 1, 2025

Touchstone Small Company Fund Q3 2025 Performance Review

The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, 2025. Among the Fund's top-performing sectors in terms of adding value were Financials and Consumer Staples. From a factor perspective, the Fund's focus on profitable, liquid, and higher quality small cap stocks negatively impacted relative performance during the quarter.

Seeking Alpha • Nov 27, 2025

Certara, Inc. (CERT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Certara, Inc. ( CERT ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants William Feehery - CEO & Director Conference Call Participants David Windley - Jefferies LLC, Research Division Presentation David Windley Jefferies LLC, Research Division Okay. Good morning, everybody.

Seeking Alpha • Nov 18, 2025

Certara, Inc. (CERT) Presents at Stephens Annual Investment Conference 2025 Transcript

Certara, Inc. ( CERT ) Stephens Annual Investment Conference 2025 November 18, 2025 2:00 PM EST Company Participants John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants Jeffrey Garro - Stephens Inc., Research Division Presentation Jeffrey Garro Stephens Inc., Research Division I think we're at the top of the hour, so we'll kick it off. A big thank you to John Gallagher, CFO of Certara, for joining us today at the Stephens Investment Conference in Nashville.

Seeking Alpha • Nov 18, 2025

Certara, Inc. (CERT) Q3 2025 Earnings Call Transcript

Certara, Inc. ( CERT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants William Feehery - CEO & Director John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants David Deuchler - Gilmartin Group LLC Daniel Christopher Clark - Leerink Partners LLC, Research Division David Windley - Jefferies LLC, Research Division Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Brendan Smith - TD Cowen, Research Division Joseph Vruwink - Robert W. Baird & Co. Incorporated, Research Division Kyle Crews - UBS Investment Bank, Research Division Max Smock - William Blair & Company L.L.C.

Seeking Alpha • Nov 7, 2025

Certara Reports Third Quarter 2025 Financial Results

RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025.

GlobeNewsWire • Nov 6, 2025

Certara, Inc. (CERT) Q3 Earnings Surpass Estimates

Certara, Inc. (CERT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.13 per share a year ago.

Zacks Investment Research • Nov 7, 2025